|
⚲
|
| Keyboard |
| David Neafus | |
|---|---|
| Firm | |
| Address | One Broadway 14th Floor Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Sightstream Biotherapeutics Inc | 021-561030 | Executive Officer | 1.8 M of 1.8 M |
||
| Syndevrx Inc | 021-529572 | Executive Officer | 6.5 M of 20.0 M |
||
| Syndevrx Inc | 021-526459 | Executive Officer | 29.4 M of 29.4 M |
||
| Sightstream Biotherapeutics Inc | 021-490659 | Executive Officer | 0.2 M of 1.2 M |
||
| KERA Therapeutics Inc | 021-448080 | Executive Officer | |||
| Sightstream Biotherapeutics Inc | 021-448088 | Executive Officer | 3.1 M of 3.5 M |
||
| Avilar Therapeutics Inc | 021-383553 | Executive Officer | 75.3 M of 75.3 M |
||
| Syndevrx Inc | 021-358309 | Executive Officer | 23.2 M of 30.0 M |
||
| Nayan Therapeutics Inc | 021-332794 | Executive Officer | 3.0 M of 25.0 M |
||
| Syndevrx Inc | 021-308187 | Executive Officer | 0.8 M of 5.0 M |
||
| Obsidian Therapeutics Inc | 021-300326 | Executive Officer | 32.4 M of 49.9 M |
||
| Syndevrx Inc | 021-292815 | Executive Officer | 1.5 M of 2.5 M |
||
| Arrakis Therapeutics Inc | 021-281666 | Executive Officer | 13.2 M of 41.2 M |
||
| Microchips Biotech Inc | 021-242364 | Executive Officer | 18.6 M of 18.6 M |
||
| Syndevrx Inc | 021-186725 | Executive Officer | 16.3 M of 18.0 M |
||
| Pangenx Inc | 021-181341 | Executive Officer | 0.9 M of 10.1 M |
||
| Sustainx Inc | 021-156707 | Executive Officer | 20.0 M of 20.0 M |
||
| Afferent Pharmaceuticals Inc | 021-135875 | Executive Officer | 3.0 M of 23.0 M |
||
| Sustainx Inc | 021-120677 | Executive Officer | 4.0 M of 4.0 M |
||
| Link Medicine Corp | 021-76287 | Executive Officer | 40.0 M of 40.0 M |
||